An Observational Study to Learn More About Vasomotor Symptoms Burden and Treatment Patterns in Menopausal Women Before and After Participating in OASIS Studies

Launched by BAYER · Apr 22, 2025

Keywords

ClinConnect Summary

This clinical trial is called an observational study that aims to better understand the burden of vasomotor symptoms (VMS), such as hot flashes, in menopausal women. The study will gather information from women who previously participated in three OASIS studies, where they were treated with either elizanetant or a placebo (a treatment with no active ingredients). Researchers want to learn about how these women managed their symptoms before and after taking part in the OASIS studies, focusing on what treatments they used and whether they continued or stopped them.

To be eligible for this study, participants need to be women in the U.S. who took part in one of the OASIS trials for moderate-to-severe VMS related to menopause and have agreed to share their experiences. Participants can expect to complete an online survey about their treatment in the year before joining the OASIS study and allow researchers to review their medical records for treatment information six months after the study ended. Importantly, this study does not require any visits or tests; it only collects information already available from routine care.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Patients in the US who participated in one of the three OASIS trials for patients with moderate-to-severe VMS related to menopause.
• • Patients who confirmed interest in being contacted for further study communication
• • Patients who consent to be included in the registry, complete the pre-OASIS trial survey, and agree to be tokenized so that their anonymized real-world data can be accessed
• Exclusion Criteria:
• • None